Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bone Density | 176 | 2024 | 3468 | 9.730 |
Why?
|
Osteoporosis | 109 | 2023 | 1579 | 9.640 |
Why?
|
Hip Fractures | 85 | 2024 | 955 | 9.150 |
Why?
|
Osteoporotic Fractures | 39 | 2024 | 401 | 7.110 |
Why?
|
Accidental Falls | 47 | 2023 | 1062 | 4.030 |
Why?
|
Nursing Homes | 36 | 2023 | 1036 | 3.650 |
Why?
|
Bone Density Conservation Agents | 24 | 2022 | 772 | 3.140 |
Why?
|
Absorptiometry, Photon | 63 | 2023 | 1725 | 3.030 |
Why?
|
Fractures, Bone | 38 | 2023 | 1947 | 2.960 |
Why?
|
Sarcopenia | 25 | 2024 | 368 | 2.900 |
Why?
|
Bone and Bones | 31 | 2023 | 2576 | 2.550 |
Why?
|
Aorta, Abdominal | 22 | 2023 | 646 | 2.520 |
Why?
|
Spinal Fractures | 25 | 2023 | 696 | 2.150 |
Why?
|
Homes for the Aged | 20 | 2021 | 260 | 2.080 |
Why?
|
Osteoporosis, Postmenopausal | 20 | 2019 | 386 | 2.020 |
Why?
|
Hand Strength | 19 | 2021 | 448 | 1.900 |
Why?
|
Genome-Wide Association Study | 69 | 2023 | 12262 | 1.740 |
Why?
|
Aortic Diseases | 14 | 2023 | 743 | 1.720 |
Why?
|
Aging | 43 | 2023 | 8664 | 1.620 |
Why?
|
Muscle Strength | 14 | 2024 | 592 | 1.590 |
Why?
|
Vibration | 6 | 2016 | 326 | 1.570 |
Why?
|
Inheritance Patterns | 7 | 2018 | 340 | 1.550 |
Why?
|
Aged, 80 and over | 186 | 2023 | 57776 | 1.510 |
Why?
|
Vitamin D | 26 | 2018 | 3224 | 1.510 |
Why?
|
Aged | 313 | 2024 | 163288 | 1.480 |
Why?
|
Lumbar Vertebrae | 38 | 2023 | 1848 | 1.430 |
Why?
|
Femur Neck | 23 | 2020 | 309 | 1.300 |
Why?
|
Spine | 23 | 2021 | 1144 | 1.290 |
Why?
|
Diphosphonates | 10 | 2023 | 623 | 1.280 |
Why?
|
Bone Diseases, Metabolic | 6 | 2023 | 417 | 1.270 |
Why?
|
Consensus | 11 | 2024 | 2960 | 1.230 |
Why?
|
Polymorphism, Single Nucleotide | 58 | 2021 | 15520 | 1.160 |
Why?
|
Alendronate | 11 | 2021 | 171 | 1.150 |
Why?
|
Thoracic Vertebrae | 14 | 2019 | 608 | 1.100 |
Why?
|
Female | 359 | 2024 | 380193 | 1.090 |
Why?
|
Calcinosis | 15 | 2018 | 1499 | 1.080 |
Why?
|
Genetic Loci | 14 | 2021 | 2575 | 1.070 |
Why?
|
Geriatric Assessment | 12 | 2017 | 1372 | 1.050 |
Why?
|
Intra-Abdominal Fat | 3 | 2023 | 591 | 1.040 |
Why?
|
Male | 312 | 2024 | 350115 | 1.040 |
Why?
|
Humans | 466 | 2024 | 744366 | 1.020 |
Why?
|
Calcium, Dietary | 12 | 2018 | 526 | 0.990 |
Why?
|
Frail Elderly | 12 | 2022 | 693 | 0.990 |
Why?
|
Postural Balance | 11 | 2015 | 620 | 0.940 |
Why?
|
Quantitative Trait Loci | 23 | 2020 | 2019 | 0.910 |
Why?
|
Muscle Weakness | 9 | 2021 | 413 | 0.910 |
Why?
|
Diet | 28 | 2023 | 7937 | 0.910 |
Why?
|
Cohort Studies | 97 | 2024 | 40559 | 0.880 |
Why?
|
Methylmalonic Acid | 1 | 2021 | 49 | 0.800 |
Why?
|
Musculoskeletal System | 4 | 2019 | 175 | 0.790 |
Why?
|
Finite Element Analysis | 5 | 2018 | 431 | 0.790 |
Why?
|
Risk Factors | 118 | 2024 | 72296 | 0.790 |
Why?
|
Dietary Proteins | 10 | 2017 | 963 | 0.770 |
Why?
|
Vitamin B Complex | 2 | 2021 | 288 | 0.740 |
Why?
|
Protective Devices | 3 | 2010 | 71 | 0.740 |
Why?
|
Longevity | 9 | 2024 | 1071 | 0.720 |
Why?
|
Dietary Supplements | 17 | 2018 | 3296 | 0.720 |
Why?
|
Middle Aged | 185 | 2023 | 213390 | 0.710 |
Why?
|
Bone Remodeling | 6 | 2017 | 575 | 0.710 |
Why?
|
Mobility Limitation | 9 | 2021 | 409 | 0.700 |
Why?
|
Mannose-Binding Lectin | 1 | 2020 | 150 | 0.700 |
Why?
|
Hip | 9 | 2012 | 257 | 0.690 |
Why?
|
Dairy Products | 6 | 2022 | 498 | 0.690 |
Why?
|
Independent Living | 10 | 2023 | 568 | 0.680 |
Why?
|
Thinness | 4 | 2017 | 480 | 0.670 |
Why?
|
Longitudinal Studies | 42 | 2023 | 13991 | 0.670 |
Why?
|
Activities of Daily Living | 16 | 2023 | 2419 | 0.660 |
Why?
|
Equipment and Supplies | 2 | 2012 | 281 | 0.660 |
Why?
|
Body Composition | 16 | 2020 | 2402 | 0.660 |
Why?
|
Muscle, Skeletal | 13 | 2023 | 4925 | 0.650 |
Why?
|
Genetic Predisposition to Disease | 28 | 2021 | 17446 | 0.650 |
Why?
|
Protective Clothing | 2 | 2010 | 102 | 0.640 |
Why?
|
Calcaneus | 6 | 2022 | 138 | 0.620 |
Why?
|
National Institutes of Health (U.S.) | 5 | 2019 | 780 | 0.620 |
Why?
|
Femur | 18 | 2015 | 1297 | 0.610 |
Why?
|
Risk Assessment | 26 | 2024 | 23336 | 0.600 |
Why?
|
DNA Methylation | 11 | 2023 | 4285 | 0.570 |
Why?
|
Vitamin D Deficiency | 6 | 2017 | 1343 | 0.570 |
Why?
|
Radius | 6 | 2022 | 422 | 0.570 |
Why?
|
Sex Characteristics | 13 | 2018 | 2585 | 0.560 |
Why?
|
RANK Ligand | 3 | 2014 | 326 | 0.560 |
Why?
|
Pelvic Bones | 3 | 2019 | 265 | 0.550 |
Why?
|
Genome, Human | 13 | 2021 | 4420 | 0.550 |
Why?
|
Advisory Committees | 1 | 2020 | 775 | 0.540 |
Why?
|
Genetic Variation | 9 | 2021 | 6542 | 0.530 |
Why?
|
Critical Pathways | 1 | 2019 | 476 | 0.520 |
Why?
|
Kyphosis | 5 | 2019 | 237 | 0.520 |
Why?
|
Vesicular Transport Proteins | 1 | 2018 | 377 | 0.510 |
Why?
|
Tomography, X-Ray Computed | 29 | 2023 | 20130 | 0.510 |
Why?
|
Vitamin B 12 | 3 | 2021 | 527 | 0.500 |
Why?
|
Genetic Linkage | 9 | 2010 | 2421 | 0.480 |
Why?
|
Sex Factors | 32 | 2021 | 10400 | 0.480 |
Why?
|
Incidence | 33 | 2023 | 20952 | 0.470 |
Why?
|
Phenotype | 24 | 2022 | 16367 | 0.470 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2015 | 370 | 0.450 |
Why?
|
GTPase-Activating Proteins | 1 | 2016 | 498 | 0.450 |
Why?
|
Adult | 107 | 2023 | 214052 | 0.440 |
Why?
|
Muscles | 6 | 2023 | 1614 | 0.440 |
Why?
|
Calibration | 2 | 2019 | 816 | 0.440 |
Why?
|
Genomics | 7 | 2022 | 5717 | 0.440 |
Why?
|
Testosterone | 9 | 2021 | 2419 | 0.440 |
Why?
|
Vitamin K 1 | 4 | 2007 | 48 | 0.440 |
Why?
|
Medicare | 20 | 2023 | 6566 | 0.440 |
Why?
|
Massachusetts | 29 | 2015 | 8662 | 0.440 |
Why?
|
Tibia | 7 | 2022 | 1077 | 0.430 |
Why?
|
Epigenesis, Genetic | 11 | 2023 | 3646 | 0.430 |
Why?
|
Estradiol | 7 | 2018 | 2020 | 0.430 |
Why?
|
Silicon | 3 | 2009 | 145 | 0.430 |
Why?
|
Quantitative Trait, Heritable | 6 | 2018 | 544 | 0.430 |
Why?
|
Gait | 8 | 2021 | 793 | 0.420 |
Why?
|
Long-Term Care | 5 | 2016 | 607 | 0.420 |
Why?
|
Flavonols | 2 | 2023 | 83 | 0.420 |
Why?
|
Tai Ji | 3 | 2012 | 285 | 0.420 |
Why?
|
Osteoprotegerin | 2 | 2014 | 176 | 0.420 |
Why?
|
Polymorphism, Genetic | 7 | 2014 | 4328 | 0.410 |
Why?
|
Age Factors | 39 | 2020 | 18373 | 0.410 |
Why?
|
Patient Compliance | 6 | 2012 | 2684 | 0.410 |
Why?
|
Vitamin K | 4 | 2010 | 295 | 0.400 |
Why?
|
Calcium | 15 | 2022 | 5755 | 0.400 |
Why?
|
Dementia | 3 | 2021 | 2518 | 0.390 |
Why?
|
Body Mass Index | 27 | 2023 | 12721 | 0.390 |
Why?
|
Genotype | 23 | 2021 | 12952 | 0.390 |
Why?
|
Homocysteine | 4 | 2013 | 647 | 0.390 |
Why?
|
Postmenopause | 14 | 2019 | 2460 | 0.380 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2012 | 135 | 0.380 |
Why?
|
Antihypertensive Agents | 3 | 2023 | 2047 | 0.380 |
Why?
|
Genetic Pleiotropy | 4 | 2019 | 182 | 0.380 |
Why?
|
Milk | 6 | 2022 | 450 | 0.380 |
Why?
|
Atherosclerosis | 6 | 2022 | 3444 | 0.380 |
Why?
|
Folic Acid | 3 | 2021 | 1300 | 0.370 |
Why?
|
Cross-Sectional Studies | 43 | 2024 | 25039 | 0.370 |
Why?
|
Linkage Disequilibrium | 10 | 2020 | 1997 | 0.360 |
Why?
|
Proportional Hazards Models | 18 | 2020 | 12356 | 0.360 |
Why?
|
LDL-Receptor Related Proteins | 2 | 2008 | 115 | 0.360 |
Why?
|
Ascorbic Acid | 4 | 2023 | 651 | 0.350 |
Why?
|
Sex Hormone-Binding Globulin | 5 | 2013 | 548 | 0.350 |
Why?
|
Research Design | 8 | 2024 | 5984 | 0.350 |
Why?
|
Disabled Persons | 5 | 2018 | 1212 | 0.350 |
Why?
|
Estrogen Replacement Therapy | 10 | 2014 | 1203 | 0.340 |
Why?
|
Prospective Studies | 47 | 2024 | 53290 | 0.340 |
Why?
|
Skilled Nursing Facilities | 3 | 2023 | 372 | 0.340 |
Why?
|
Benzodiazepines | 1 | 2015 | 1101 | 0.340 |
Why?
|
Alcoholic Beverages | 2 | 2009 | 265 | 0.340 |
Why?
|
United States | 51 | 2023 | 69872 | 0.340 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2023 | 954 | 0.340 |
Why?
|
Bone Resorption | 6 | 2017 | 723 | 0.330 |
Why?
|
Adipose Tissue | 7 | 2023 | 3280 | 0.330 |
Why?
|
Mendelian Randomization Analysis | 6 | 2020 | 967 | 0.330 |
Why?
|
Carotenoids | 4 | 2022 | 624 | 0.330 |
Why?
|
Bone Diseases | 1 | 2012 | 416 | 0.330 |
Why?
|
Cardiovascular Diseases | 11 | 2022 | 15160 | 0.320 |
Why?
|
Wnt Proteins | 3 | 2015 | 721 | 0.320 |
Why?
|
Vegetables | 5 | 2020 | 1182 | 0.320 |
Why?
|
Body Fluid Compartments | 2 | 2019 | 52 | 0.310 |
Why?
|
Follow-Up Studies | 37 | 2023 | 39052 | 0.310 |
Why?
|
Resistance Training | 3 | 2021 | 164 | 0.310 |
Why?
|
Estrogens | 7 | 2014 | 1566 | 0.300 |
Why?
|
Radiography | 25 | 2014 | 7023 | 0.300 |
Why?
|
Family Characteristics | 1 | 2012 | 1000 | 0.290 |
Why?
|
Fruit | 5 | 2016 | 1142 | 0.290 |
Why?
|
Body Height | 3 | 2012 | 1578 | 0.290 |
Why?
|
Reminder Systems | 1 | 2010 | 371 | 0.290 |
Why?
|
Hand | 3 | 2017 | 884 | 0.290 |
Why?
|
Receptors, Calcitriol | 2 | 2000 | 348 | 0.280 |
Why?
|
Vascular Diseases | 3 | 2023 | 1161 | 0.280 |
Why?
|
Menarche | 4 | 2018 | 516 | 0.280 |
Why?
|
Insulin-Like Growth Factor I | 7 | 2002 | 2016 | 0.270 |
Why?
|
Habits | 1 | 2006 | 139 | 0.270 |
Why?
|
Eating | 6 | 2022 | 1536 | 0.260 |
Why?
|
Carbonated Beverages | 1 | 2006 | 214 | 0.260 |
Why?
|
Alcohol Drinking | 7 | 2009 | 3966 | 0.260 |
Why?
|
Life Style | 5 | 2020 | 3835 | 0.250 |
Why?
|
Adiposity | 4 | 2023 | 1806 | 0.250 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5749 | 0.250 |
Why?
|
Linear Models | 12 | 2021 | 5953 | 0.250 |
Why?
|
Quadriceps Muscle | 2 | 2017 | 144 | 0.250 |
Why?
|
Institutionalization | 2 | 1995 | 104 | 0.250 |
Why?
|
Vitamins | 4 | 2023 | 1623 | 0.250 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2007 | 689 | 0.250 |
Why?
|
Exercise | 7 | 2020 | 5615 | 0.240 |
Why?
|
Arteriosclerosis | 5 | 2002 | 1092 | 0.240 |
Why?
|
Age Distribution | 9 | 2016 | 2902 | 0.240 |
Why?
|
Confidence Intervals | 10 | 2016 | 2971 | 0.240 |
Why?
|
CpG Islands | 5 | 2023 | 1170 | 0.240 |
Why?
|
Premenopause | 4 | 2013 | 1033 | 0.230 |
Why?
|
Mental Recall | 1 | 2010 | 1206 | 0.230 |
Why?
|
Hyperhomocysteinemia | 1 | 2004 | 124 | 0.230 |
Why?
|
Body Size | 4 | 2012 | 461 | 0.230 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2004 | 116 | 0.230 |
Why?
|
Retrospective Studies | 33 | 2024 | 77460 | 0.230 |
Why?
|
Coronary Artery Disease | 5 | 2022 | 6486 | 0.230 |
Why?
|
Cross-Over Studies | 3 | 2015 | 2029 | 0.230 |
Why?
|
Cause of Death | 5 | 2020 | 3582 | 0.220 |
Why?
|
Meta-Analysis as Topic | 6 | 2020 | 1342 | 0.220 |
Why?
|
Smoking | 13 | 2016 | 8987 | 0.220 |
Why?
|
Leukotriene B4 | 2 | 1996 | 294 | 0.220 |
Why?
|
Insulin-Like Growth Factor Binding Protein 4 | 1 | 2002 | 26 | 0.220 |
Why?
|
Wounds and Injuries | 3 | 2014 | 2400 | 0.220 |
Why?
|
Feeding Behavior | 6 | 2018 | 3188 | 0.220 |
Why?
|
Insulin-Like Growth Factor Binding Protein 5 | 1 | 2002 | 27 | 0.220 |
Why?
|
Predictive Value of Tests | 10 | 2020 | 15078 | 0.220 |
Why?
|
Quercetin | 1 | 2023 | 93 | 0.220 |
Why?
|
Weight-Bearing | 3 | 2017 | 515 | 0.210 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2017 | 563 | 0.210 |
Why?
|
Interleukin-6 | 4 | 2022 | 3203 | 0.210 |
Why?
|
Self Report | 2 | 2013 | 3553 | 0.210 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2003 | 284 | 0.210 |
Why?
|
Extracellular Matrix Proteins | 4 | 2019 | 850 | 0.210 |
Why?
|
Chromosome Mapping | 5 | 2020 | 4740 | 0.210 |
Why?
|
Principal Component Analysis | 2 | 2012 | 940 | 0.210 |
Why?
|
Dose-Response Relationship, Drug | 9 | 2015 | 10943 | 0.210 |
Why?
|
Heat-Shock Proteins | 2 | 2019 | 822 | 0.210 |
Why?
|
Least-Squares Analysis | 3 | 2017 | 379 | 0.210 |
Why?
|
Guideline Adherence | 2 | 2010 | 2265 | 0.210 |
Why?
|
Risk | 8 | 2013 | 9688 | 0.210 |
Why?
|
Boston | 8 | 2022 | 9312 | 0.200 |
Why?
|
Hospitalization | 8 | 2023 | 10259 | 0.200 |
Why?
|
Antipsychotic Agents | 1 | 2015 | 3057 | 0.200 |
Why?
|
Acceleration | 1 | 2022 | 181 | 0.200 |
Why?
|
Cholesterol | 3 | 2004 | 2919 | 0.200 |
Why?
|
Blood Vessels | 1 | 2007 | 1125 | 0.200 |
Why?
|
Mitochondrial Membrane Transport Proteins | 2 | 2020 | 154 | 0.200 |
Why?
|
Versicans | 2 | 2019 | 33 | 0.200 |
Why?
|
Spinal Curvatures | 2 | 2016 | 66 | 0.200 |
Why?
|
Ultrasonography | 11 | 2022 | 5984 | 0.200 |
Why?
|
Patient Education as Topic | 2 | 2020 | 2278 | 0.190 |
Why?
|
Time Factors | 18 | 2020 | 40075 | 0.190 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 2 | 2021 | 137 | 0.190 |
Why?
|
Observer Variation | 7 | 2011 | 2593 | 0.190 |
Why?
|
Diet Surveys | 6 | 2022 | 1173 | 0.190 |
Why?
|
Elder Nutritional Physiological Phenomena | 1 | 2020 | 7 | 0.190 |
Why?
|
Acid-Base Equilibrium | 1 | 2001 | 185 | 0.190 |
Why?
|
Brassicaceae | 1 | 2020 | 10 | 0.190 |
Why?
|
Calcifediol | 2 | 2016 | 166 | 0.190 |
Why?
|
Alleles | 10 | 2014 | 6933 | 0.190 |
Why?
|
Brassica | 1 | 2020 | 38 | 0.190 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6539 | 0.190 |
Why?
|
Vitamin K Deficiency | 1 | 2000 | 24 | 0.180 |
Why?
|
Alzheimer Disease | 6 | 2023 | 8038 | 0.180 |
Why?
|
Apolipoproteins E | 4 | 2014 | 1438 | 0.180 |
Why?
|
Magnesium | 3 | 2002 | 813 | 0.180 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2002 | 658 | 0.180 |
Why?
|
Vitamin B 6 | 1 | 2021 | 237 | 0.180 |
Why?
|
Multivariate Analysis | 14 | 2019 | 12244 | 0.180 |
Why?
|
Obesity | 9 | 2023 | 12746 | 0.180 |
Why?
|
Randomized Controlled Trials as Topic | 10 | 2018 | 9955 | 0.180 |
Why?
|
Regression Analysis | 12 | 2018 | 6459 | 0.170 |
Why?
|
Caffeine | 3 | 2014 | 699 | 0.170 |
Why?
|
Osteocalcin | 3 | 2006 | 273 | 0.170 |
Why?
|
Blood Cells | 2 | 2022 | 309 | 0.170 |
Why?
|
Hip Joint | 5 | 2012 | 1002 | 0.170 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 314 | 0.170 |
Why?
|
Analysis of Variance | 7 | 2010 | 6366 | 0.170 |
Why?
|
Logistic Models | 13 | 2022 | 13409 | 0.170 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2023 | 11726 | 0.170 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2000 | 462 | 0.170 |
Why?
|
Antidepressive Agents | 1 | 2011 | 2838 | 0.170 |
Why?
|
Apolipoprotein E2 | 1 | 2019 | 127 | 0.170 |
Why?
|
Musculoskeletal Physiological Phenomena | 1 | 2019 | 30 | 0.170 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2019 | 170 | 0.170 |
Why?
|
Gene Regulatory Networks | 4 | 2022 | 1707 | 0.170 |
Why?
|
Odds Ratio | 17 | 2022 | 9849 | 0.160 |
Why?
|
Apolipoprotein E4 | 2 | 2019 | 668 | 0.160 |
Why?
|
Access to Information | 1 | 2022 | 320 | 0.160 |
Why?
|
Haplotypes | 5 | 2021 | 2779 | 0.160 |
Why?
|
Reproducibility of Results | 16 | 2019 | 19905 | 0.160 |
Why?
|
Fatty Acids, Unsaturated | 2 | 2012 | 546 | 0.160 |
Why?
|
Australia | 4 | 2023 | 1167 | 0.160 |
Why?
|
Teriparatide | 3 | 2021 | 225 | 0.160 |
Why?
|
Organ Size | 7 | 2018 | 2251 | 0.160 |
Why?
|
Troponin I | 1 | 2022 | 619 | 0.160 |
Why?
|
Body Weight | 6 | 2023 | 4671 | 0.160 |
Why?
|
Soft Tissue Injuries | 1 | 2019 | 176 | 0.150 |
Why?
|
Animals | 32 | 2022 | 168768 | 0.150 |
Why?
|
Fracture Fixation | 1 | 2020 | 354 | 0.150 |
Why?
|
Biomedical Research | 2 | 2011 | 3309 | 0.150 |
Why?
|
Musculoskeletal Development | 1 | 2017 | 14 | 0.150 |
Why?
|
Sex Distribution | 6 | 2010 | 2297 | 0.150 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 1 | 2017 | 55 | 0.150 |
Why?
|
Aromatase | 1 | 2018 | 147 | 0.150 |
Why?
|
Mortality | 6 | 2021 | 2864 | 0.150 |
Why?
|
Dietary Fiber | 2 | 2021 | 760 | 0.150 |
Why?
|
Prevalence | 10 | 2020 | 15221 | 0.150 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2017 | 88 | 0.150 |
Why?
|
Back Pain | 3 | 2006 | 545 | 0.150 |
Why?
|
Excitatory Amino Acid Transporter 1 | 1 | 2016 | 19 | 0.150 |
Why?
|
Amidohydrolases | 1 | 2018 | 169 | 0.150 |
Why?
|
Isosorbide Dinitrate | 1 | 2016 | 34 | 0.140 |
Why?
|
Motor Activity | 5 | 2015 | 2715 | 0.140 |
Why?
|
Receptor, EphB2 | 1 | 2016 | 25 | 0.140 |
Why?
|
Atrial Fibrillation | 3 | 2023 | 5035 | 0.140 |
Why?
|
Nutrition Disorders | 1 | 1997 | 211 | 0.140 |
Why?
|
Electric Impedance | 2 | 2019 | 729 | 0.140 |
Why?
|
Estrone | 2 | 2018 | 240 | 0.140 |
Why?
|
Minerals | 2 | 2023 | 275 | 0.140 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2017 | 326 | 0.140 |
Why?
|
Drug Utilization Review | 1 | 2017 | 245 | 0.140 |
Why?
|
Femur Head | 1 | 2018 | 301 | 0.140 |
Why?
|
Patient Acceptance of Health Care | 1 | 2010 | 3020 | 0.140 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1997 | 769 | 0.140 |
Why?
|
Phospholipase D | 1 | 1996 | 70 | 0.140 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2017 | 186 | 0.140 |
Why?
|
Menopause | 4 | 2018 | 1626 | 0.140 |
Why?
|
Zygapophyseal Joint | 1 | 2018 | 129 | 0.140 |
Why?
|
Europe | 6 | 2021 | 3338 | 0.140 |
Why?
|
Multifactorial Inheritance | 2 | 2020 | 1195 | 0.140 |
Why?
|
Oxandrolone | 1 | 2015 | 23 | 0.140 |
Why?
|
Promoter Regions, Genetic | 3 | 2019 | 5867 | 0.140 |
Why?
|
Tooth Loss | 1 | 1998 | 197 | 0.140 |
Why?
|
Comorbidity | 8 | 2019 | 10388 | 0.130 |
Why?
|
Calcium-Binding Proteins | 3 | 2014 | 1081 | 0.130 |
Why?
|
Fractures, Spontaneous | 3 | 2007 | 230 | 0.130 |
Why?
|
Tooth | 1 | 1997 | 207 | 0.130 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2021 | 1240 | 0.130 |
Why?
|
Musculoskeletal Diseases | 1 | 2022 | 581 | 0.130 |
Why?
|
Osteoarthritis, Knee | 4 | 2007 | 1222 | 0.130 |
Why?
|
Double-Blind Method | 12 | 2019 | 12025 | 0.130 |
Why?
|
Diet, Mediterranean | 1 | 2022 | 700 | 0.130 |
Why?
|
Young Adult | 13 | 2021 | 56429 | 0.130 |
Why?
|
Microsatellite Repeats | 3 | 2003 | 802 | 0.130 |
Why?
|
Lod Score | 3 | 2012 | 614 | 0.130 |
Why?
|
Cholecalciferol | 2 | 2011 | 535 | 0.130 |
Why?
|
Office Visits | 1 | 2000 | 598 | 0.130 |
Why?
|
Walking | 3 | 2021 | 1180 | 0.130 |
Why?
|
Twins | 1 | 2017 | 339 | 0.130 |
Why?
|
Posture | 2 | 2010 | 958 | 0.130 |
Why?
|
Receptors, Estrogen | 1 | 2003 | 2190 | 0.130 |
Why?
|
Nitroglycerin | 1 | 2016 | 325 | 0.130 |
Why?
|
Disability Evaluation | 4 | 2020 | 1828 | 0.130 |
Why?
|
Gene Frequency | 3 | 2017 | 3587 | 0.130 |
Why?
|
Physical Exertion | 1 | 1998 | 695 | 0.130 |
Why?
|
MicroRNAs | 2 | 2022 | 3751 | 0.130 |
Why?
|
Biphenyl Compounds | 1 | 2019 | 913 | 0.130 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2013 | 380 | 0.130 |
Why?
|
Procollagen | 1 | 2015 | 185 | 0.130 |
Why?
|
Potassium | 1 | 1999 | 1336 | 0.120 |
Why?
|
Life Expectancy | 3 | 2019 | 1184 | 0.120 |
Why?
|
Health Services Needs and Demand | 1 | 2022 | 1410 | 0.120 |
Why?
|
Geriatrics | 3 | 2019 | 397 | 0.120 |
Why?
|
Sodium Chloride Symporter Inhibitors | 2 | 2012 | 76 | 0.120 |
Why?
|
Leukocytes | 3 | 2018 | 2045 | 0.120 |
Why?
|
Weight Loss | 3 | 2023 | 2625 | 0.120 |
Why?
|
Geography | 1 | 2016 | 669 | 0.120 |
Why?
|
Aortography | 1 | 2015 | 437 | 0.120 |
Why?
|
Epigenomics | 1 | 2019 | 903 | 0.120 |
Why?
|
Pneumonia | 2 | 2020 | 2133 | 0.120 |
Why?
|
Genes, Y-Linked | 1 | 2013 | 11 | 0.120 |
Why?
|
Case-Control Studies | 13 | 2020 | 21748 | 0.120 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2014 | 299 | 0.120 |
Why?
|
Extremities | 2 | 2017 | 866 | 0.120 |
Why?
|
Forecasting | 2 | 2013 | 2951 | 0.110 |
Why?
|
Research Report | 1 | 2016 | 355 | 0.110 |
Why?
|
Knee Joint | 3 | 2007 | 1680 | 0.110 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 676 | 0.110 |
Why?
|
Exercise Therapy | 4 | 2012 | 904 | 0.110 |
Why?
|
Anabolic Agents | 1 | 2015 | 247 | 0.110 |
Why?
|
Yogurt | 1 | 2013 | 72 | 0.110 |
Why?
|
Reference Standards | 1 | 2016 | 1025 | 0.110 |
Why?
|
Arachidonic Acid | 2 | 2011 | 434 | 0.110 |
Why?
|
Multiple Sclerosis | 2 | 2018 | 3079 | 0.110 |
Why?
|
Placebos | 2 | 2015 | 1676 | 0.110 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2014 | 437 | 0.110 |
Why?
|
Telomerase | 1 | 2018 | 730 | 0.110 |
Why?
|
Gonadal Steroid Hormones | 2 | 2018 | 711 | 0.110 |
Why?
|
Integrin alpha1 | 1 | 2012 | 13 | 0.110 |
Why?
|
Coronary Disease | 4 | 2009 | 6077 | 0.110 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2014 | 354 | 0.110 |
Why?
|
Thyroid Hormone Receptors alpha | 1 | 2012 | 14 | 0.110 |
Why?
|
Mass Screening | 3 | 2020 | 5253 | 0.100 |
Why?
|
Genes | 2 | 2013 | 1893 | 0.100 |
Why?
|
GATA Transcription Factors | 1 | 2012 | 30 | 0.100 |
Why?
|
Collagen Type I | 1 | 2015 | 592 | 0.100 |
Why?
|
Genetics, Population | 1 | 2017 | 934 | 0.100 |
Why?
|
Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2012 | 32 | 0.100 |
Why?
|
Diuretics | 2 | 2012 | 591 | 0.100 |
Why?
|
Vasodilator Agents | 1 | 2016 | 976 | 0.100 |
Why?
|
Fishes | 2 | 2015 | 569 | 0.100 |
Why?
|
Seafood | 2 | 2015 | 384 | 0.100 |
Why?
|
Fee-for-Service Plans | 1 | 2017 | 694 | 0.100 |
Why?
|
Sensation Disorders | 1 | 2012 | 156 | 0.100 |
Why?
|
Genetic Association Studies | 3 | 2016 | 2703 | 0.100 |
Why?
|
Evidence-Based Medicine | 4 | 2020 | 3611 | 0.100 |
Why?
|
Methyltransferases | 1 | 2014 | 367 | 0.100 |
Why?
|
Benzothiadiazines | 1 | 1991 | 32 | 0.100 |
Why?
|
Carrier Proteins | 2 | 2017 | 5023 | 0.100 |
Why?
|
Goals | 1 | 2016 | 707 | 0.100 |
Why?
|
Adolescent | 11 | 2021 | 85779 | 0.100 |
Why?
|
France | 1 | 2012 | 517 | 0.100 |
Why?
|
Severity of Illness Index | 6 | 2017 | 15535 | 0.100 |
Why?
|
Phosphate Transport Proteins | 1 | 2010 | 8 | 0.100 |
Why?
|
Immunity | 2 | 2019 | 1014 | 0.090 |
Why?
|
Analgesics | 1 | 2017 | 1040 | 0.090 |
Why?
|
Practice Guidelines as Topic | 2 | 2010 | 7282 | 0.090 |
Why?
|
Genetic Markers | 4 | 2016 | 2634 | 0.090 |
Why?
|
alpha-Linolenic Acid | 1 | 2011 | 144 | 0.090 |
Why?
|
Refusal to Participate | 1 | 2010 | 24 | 0.090 |
Why?
|
Memantine | 1 | 2011 | 100 | 0.090 |
Why?
|
Phosphatidylcholines | 1 | 2012 | 411 | 0.090 |
Why?
|
Societies, Scientific | 1 | 2011 | 220 | 0.090 |
Why?
|
Acids | 1 | 2011 | 127 | 0.090 |
Why?
|
Homeodomain Proteins | 3 | 2015 | 2418 | 0.090 |
Why?
|
Dopamine Agents | 1 | 2011 | 189 | 0.090 |
Why?
|
Administration, Oral | 6 | 2023 | 3914 | 0.090 |
Why?
|
Osteoarthritis | 1 | 2018 | 1036 | 0.090 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2011 | 238 | 0.090 |
Why?
|
Quebec | 2 | 2007 | 134 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2016 | 3921 | 0.090 |
Why?
|
Nootropic Agents | 1 | 2011 | 160 | 0.090 |
Why?
|
Mice | 12 | 2021 | 81201 | 0.090 |
Why?
|
Drinking | 1 | 2011 | 197 | 0.090 |
Why?
|
Pyrophosphatases | 1 | 2010 | 137 | 0.090 |
Why?
|
Metacarpus | 4 | 2004 | 35 | 0.090 |
Why?
|
Patient Selection | 5 | 2010 | 4216 | 0.090 |
Why?
|
Gene Expression Regulation | 8 | 2019 | 12073 | 0.090 |
Why?
|
Calcification, Physiologic | 1 | 2010 | 169 | 0.090 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2011 | 226 | 0.090 |
Why?
|
Cholinesterase Inhibitors | 1 | 2011 | 238 | 0.090 |
Why?
|
Terminal Care | 1 | 2021 | 1694 | 0.090 |
Why?
|
Disease Management | 1 | 2020 | 2460 | 0.090 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2014 | 1677 | 0.090 |
Why?
|
Child | 9 | 2021 | 77709 | 0.090 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2010 | 197 | 0.090 |
Why?
|
Outpatients | 1 | 2017 | 1487 | 0.090 |
Why?
|
Protective Agents | 1 | 2010 | 156 | 0.080 |
Why?
|
Physician-Patient Relations | 1 | 2002 | 3229 | 0.080 |
Why?
|
Membrane Proteins | 5 | 2017 | 7882 | 0.080 |
Why?
|
Family | 2 | 2018 | 3147 | 0.080 |
Why?
|
C-Reactive Protein | 3 | 2022 | 3778 | 0.080 |
Why?
|
Beer | 1 | 2009 | 127 | 0.080 |
Why?
|
Recurrence | 3 | 2012 | 8340 | 0.080 |
Why?
|
Hallux Valgus | 1 | 2009 | 65 | 0.080 |
Why?
|
DNA Copy Number Variations | 3 | 2013 | 1941 | 0.080 |
Why?
|
Obesity, Abdominal | 2 | 2023 | 361 | 0.080 |
Why?
|
Estrogen Receptor alpha | 1 | 2013 | 577 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2001 | 2542 | 0.080 |
Why?
|
Multicenter Studies as Topic | 2 | 2018 | 1677 | 0.080 |
Why?
|
Interviews as Topic | 3 | 2012 | 2539 | 0.080 |
Why?
|
Congresses as Topic | 1 | 2013 | 764 | 0.080 |
Why?
|
Thyrotropin | 2 | 2012 | 849 | 0.080 |
Why?
|
Medication Adherence | 2 | 2010 | 2063 | 0.080 |
Why?
|
Rehabilitation Centers | 1 | 2010 | 254 | 0.080 |
Why?
|
Wine | 1 | 2009 | 165 | 0.080 |
Why?
|
Health | 1 | 2011 | 394 | 0.080 |
Why?
|
Medical Audit | 1 | 2010 | 467 | 0.080 |
Why?
|
Health Services for the Aged | 1 | 1991 | 269 | 0.080 |
Why?
|
Calcitonin | 2 | 2018 | 336 | 0.080 |
Why?
|
Accidents | 1 | 1989 | 164 | 0.080 |
Why?
|
Osteogenesis | 2 | 2013 | 1299 | 0.080 |
Why?
|
Clodronic Acid | 1 | 2008 | 60 | 0.080 |
Why?
|
Syncope | 1 | 2011 | 429 | 0.080 |
Why?
|
RNA, Messenger | 3 | 2022 | 13035 | 0.080 |
Why?
|
Educational Status | 4 | 2009 | 2540 | 0.080 |
Why?
|
Cognition | 4 | 2018 | 6770 | 0.080 |
Why?
|
Heterozygote | 4 | 2021 | 2804 | 0.080 |
Why?
|
Metacarpal Bones | 1 | 2008 | 73 | 0.080 |
Why?
|
Amides | 1 | 1991 | 459 | 0.080 |
Why?
|
Pressure Ulcer | 1 | 2009 | 155 | 0.080 |
Why?
|
Anorexia Nervosa | 1 | 2016 | 1286 | 0.080 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 8949 | 0.080 |
Why?
|
Pain, Postoperative | 1 | 2017 | 1643 | 0.080 |
Why?
|
Genetic Testing | 2 | 2015 | 3444 | 0.080 |
Why?
|
Nutrition Assessment | 3 | 2016 | 723 | 0.080 |
Why?
|
Cells, Cultured | 6 | 2021 | 19233 | 0.080 |
Why?
|
Ethanol | 2 | 2009 | 1342 | 0.070 |
Why?
|
Nutritional Status | 5 | 2013 | 1609 | 0.070 |
Why?
|
Matched-Pair Analysis | 1 | 2008 | 288 | 0.070 |
Why?
|
Influenza, Human | 1 | 2018 | 1479 | 0.070 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2009 | 535 | 0.070 |
Why?
|
Rhode Island | 4 | 1998 | 347 | 0.070 |
Why?
|
Public Health | 2 | 2019 | 2602 | 0.070 |
Why?
|
Heart Valve Diseases | 1 | 2015 | 1074 | 0.070 |
Why?
|
Growth Hormone | 3 | 2001 | 705 | 0.070 |
Why?
|
Treatment Outcome | 10 | 2019 | 63107 | 0.070 |
Why?
|
Standard of Care | 1 | 2011 | 564 | 0.070 |
Why?
|
Forkhead Transcription Factors | 1 | 2014 | 1613 | 0.070 |
Why?
|
Alkaline Phosphatase | 1 | 2010 | 867 | 0.070 |
Why?
|
Energy Intake | 4 | 2020 | 2148 | 0.070 |
Why?
|
Sequence Deletion | 1 | 2011 | 1525 | 0.070 |
Why?
|
Telephone | 1 | 2010 | 617 | 0.070 |
Why?
|
Potassium, Dietary | 2 | 2009 | 96 | 0.070 |
Why?
|
Health Surveys | 3 | 2020 | 4036 | 0.070 |
Why?
|
Stroke | 3 | 2023 | 9981 | 0.070 |
Why?
|
Movement | 2 | 2012 | 1471 | 0.070 |
Why?
|
Etidronic Acid | 1 | 2006 | 64 | 0.070 |
Why?
|
Pedigree | 5 | 2007 | 4642 | 0.070 |
Why?
|
Appointments and Schedules | 1 | 2010 | 417 | 0.070 |
Why?
|
Exostoses | 1 | 2006 | 30 | 0.070 |
Why?
|
Algorithms | 6 | 2016 | 13882 | 0.070 |
Why?
|
Phosphoproteins | 2 | 2012 | 2441 | 0.070 |
Why?
|
Meat | 2 | 2015 | 592 | 0.070 |
Why?
|
Materials Testing | 1 | 2009 | 867 | 0.070 |
Why?
|
Pharyngeal Muscles | 1 | 1986 | 77 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2134 | 0.070 |
Why?
|
Urine | 1 | 1987 | 370 | 0.070 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2011 | 1157 | 0.070 |
Why?
|
Environment | 1 | 2012 | 1123 | 0.070 |
Why?
|
Mental Status Schedule | 2 | 2005 | 321 | 0.070 |
Why?
|
NF-kappa B | 1 | 2014 | 2499 | 0.070 |
Why?
|
Warfarin | 1 | 2014 | 1497 | 0.070 |
Why?
|
Heptanoic Acids | 1 | 2007 | 343 | 0.070 |
Why?
|
Intermittent Claudication | 1 | 2008 | 309 | 0.070 |
Why?
|
Arthralgia | 1 | 2009 | 456 | 0.070 |
Why?
|
PPAR gamma | 1 | 2008 | 493 | 0.060 |
Why?
|
Genetic Heterogeneity | 2 | 2012 | 733 | 0.060 |
Why?
|
Intelligence | 1 | 2010 | 920 | 0.060 |
Why?
|
Hypertension | 2 | 2023 | 8479 | 0.060 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2014 | 555 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2014 | 4424 | 0.060 |
Why?
|
Age Determination by Skeleton | 1 | 2005 | 129 | 0.060 |
Why?
|
Metabolome | 1 | 2011 | 895 | 0.060 |
Why?
|
New Hampshire | 2 | 2018 | 172 | 0.060 |
Why?
|
Receptors, Immunologic | 1 | 1991 | 1423 | 0.060 |
Why?
|
Anticoagulants | 2 | 2023 | 4600 | 0.060 |
Why?
|
Morbidity | 3 | 2023 | 1768 | 0.060 |
Why?
|
Internal Medicine | 1 | 1991 | 1009 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3154 | 0.060 |
Why?
|
Thiazides | 1 | 2023 | 18 | 0.060 |
Why?
|
Polymerase Chain Reaction | 2 | 2006 | 6171 | 0.060 |
Why?
|
Survival Rate | 4 | 2018 | 12788 | 0.060 |
Why?
|
Clinical Protocols | 1 | 2010 | 1461 | 0.060 |
Why?
|
Leg | 1 | 2009 | 1116 | 0.060 |
Why?
|
Molecular Sequence Annotation | 2 | 2016 | 528 | 0.060 |
Why?
|
Chromatography, Liquid | 2 | 2021 | 976 | 0.060 |
Why?
|
Amlodipine | 1 | 2023 | 83 | 0.060 |
Why?
|
Nuclear Proteins | 3 | 2017 | 5856 | 0.060 |
Why?
|
Chromosomes, Human, X | 2 | 2018 | 296 | 0.060 |
Why?
|
Muscular Dystrophies | 1 | 1986 | 393 | 0.060 |
Why?
|
Population Surveillance | 2 | 2008 | 2616 | 0.060 |
Why?
|
Depression | 1 | 2023 | 7759 | 0.060 |
Why?
|
Coronary Vessels | 2 | 2012 | 3107 | 0.060 |
Why?
|
Acute Disease | 2 | 2012 | 7147 | 0.060 |
Why?
|
Child, Preschool | 3 | 2021 | 41005 | 0.060 |
Why?
|
Osteoblasts | 2 | 2021 | 1166 | 0.060 |
Why?
|
Anthocyanins | 1 | 2023 | 79 | 0.060 |
Why?
|
Peptides | 1 | 2015 | 4410 | 0.060 |
Why?
|
Estrogen Receptor beta | 1 | 2003 | 175 | 0.050 |
Why?
|
Bread | 1 | 2002 | 23 | 0.050 |
Why?
|
Candy | 1 | 2002 | 37 | 0.050 |
Why?
|
Heart Diseases | 1 | 2016 | 2789 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2015 | 5096 | 0.050 |
Why?
|
Cholesterol, HDL | 1 | 1989 | 1813 | 0.050 |
Why?
|
Osteoclasts | 2 | 2021 | 729 | 0.050 |
Why?
|
Heart Failure | 2 | 2023 | 10895 | 0.050 |
Why?
|
DNA Repair | 1 | 2012 | 2046 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3135 | 0.050 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2023 | 1516 | 0.050 |
Why?
|
Biological Evolution | 1 | 2008 | 1077 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3242 | 0.050 |
Why?
|
Oculomotor Muscles | 1 | 1986 | 371 | 0.050 |
Why?
|
Recovery of Function | 2 | 2021 | 2926 | 0.050 |
Why?
|
Heart | 1 | 2015 | 4464 | 0.050 |
Why?
|
Sensitivity and Specificity | 4 | 2018 | 14723 | 0.050 |
Why?
|
Sulfonylurea Compounds | 1 | 2023 | 205 | 0.050 |
Why?
|
Sampling Studies | 2 | 2012 | 623 | 0.050 |
Why?
|
Vision Disorders | 1 | 1989 | 1058 | 0.050 |
Why?
|
Restraint, Physical | 2 | 1995 | 193 | 0.050 |
Why?
|
Safety Management | 1 | 2008 | 783 | 0.050 |
Why?
|
Patient Dropouts | 1 | 2004 | 420 | 0.050 |
Why?
|
Brachial Artery | 1 | 2023 | 369 | 0.050 |
Why?
|
Urban Population | 1 | 2010 | 2022 | 0.050 |
Why?
|
Thyroid Gland | 1 | 2008 | 1173 | 0.050 |
Why?
|
Receptors, Glucagon | 1 | 2001 | 92 | 0.050 |
Why?
|
Gene Expression Profiling | 3 | 2016 | 9445 | 0.050 |
Why?
|
Schools | 1 | 2010 | 1433 | 0.050 |
Why?
|
Tandem Mass Spectrometry | 2 | 2021 | 1157 | 0.050 |
Why?
|
South America | 1 | 2021 | 181 | 0.050 |
Why?
|
Growth Differentiation Factor 5 | 1 | 2021 | 35 | 0.050 |
Why?
|
Epidemiologic Methods | 3 | 2012 | 1364 | 0.050 |
Why?
|
Reference Values | 3 | 2023 | 4982 | 0.050 |
Why?
|
Hydrazones | 1 | 2001 | 102 | 0.050 |
Why?
|
Delphi Technique | 1 | 2024 | 779 | 0.050 |
Why?
|
Disease Susceptibility | 3 | 2014 | 1782 | 0.050 |
Why?
|
Pyrroles | 1 | 2007 | 1146 | 0.050 |
Why?
|
Weight Lifting | 1 | 2001 | 131 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2019 | 5388 | 0.050 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2021 | 106 | 0.050 |
Why?
|
Lumbosacral Region | 2 | 2000 | 310 | 0.050 |
Why?
|
Parents | 1 | 2014 | 3405 | 0.050 |
Why?
|
Heel | 1 | 2020 | 36 | 0.050 |
Why?
|
Population Density | 1 | 2021 | 196 | 0.050 |
Why?
|
Hypercholesterolemia | 2 | 2007 | 1151 | 0.050 |
Why?
|
Prognosis | 6 | 2021 | 29060 | 0.050 |
Why?
|
Equipment Design | 2 | 2009 | 3582 | 0.050 |
Why?
|
Dietary Fats | 1 | 2008 | 2016 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2016 | 1656 | 0.050 |
Why?
|
Inflammation | 3 | 2023 | 10637 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2021 | 14561 | 0.050 |
Why?
|
National Institute on Aging (U.S.) | 1 | 2019 | 32 | 0.050 |
Why?
|
Lung | 2 | 2017 | 9857 | 0.050 |
Why?
|
Deglutition Disorders | 1 | 1986 | 606 | 0.050 |
Why?
|
Lipid Peroxidation | 1 | 2021 | 270 | 0.040 |
Why?
|
Flavonoids | 1 | 2023 | 443 | 0.040 |
Why?
|
Dyslipidemias | 1 | 2007 | 849 | 0.040 |
Why?
|
Residence Characteristics | 3 | 2021 | 2050 | 0.040 |
Why?
|
Chronic Disease | 3 | 2020 | 9145 | 0.040 |
Why?
|
Asia | 1 | 2021 | 609 | 0.040 |
Why?
|
Antifibrinolytic Agents | 1 | 2002 | 254 | 0.040 |
Why?
|
DNA-Binding Proteins | 3 | 2012 | 9647 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2021 | 279 | 0.040 |
Why?
|
Transcription, Genetic | 2 | 2012 | 7721 | 0.040 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 2011 | 417 | 0.040 |
Why?
|
Anemia | 1 | 2009 | 1503 | 0.040 |
Why?
|
Triglycerides | 2 | 2004 | 2453 | 0.040 |
Why?
|
Propensity Score | 2 | 2018 | 1781 | 0.040 |
Why?
|
Binding, Competitive | 2 | 2001 | 1157 | 0.040 |
Why?
|
Maryland | 1 | 2019 | 276 | 0.040 |
Why?
|
Psychomotor Performance | 2 | 1998 | 1901 | 0.040 |
Why?
|
Vitamin E | 1 | 2023 | 869 | 0.040 |
Why?
|
Databases, Genetic | 2 | 2020 | 1783 | 0.040 |
Why?
|
Low Back Pain | 2 | 1998 | 956 | 0.040 |
Why?
|
Fish Oils | 2 | 2014 | 470 | 0.040 |
Why?
|
Quality of Life | 4 | 2019 | 12802 | 0.040 |
Why?
|
Administration, Topical | 1 | 2021 | 690 | 0.040 |
Why?
|
Nitrogen | 1 | 2020 | 344 | 0.040 |
Why?
|
Cell Differentiation | 4 | 2021 | 11486 | 0.040 |
Why?
|
Twin Studies as Topic | 1 | 2018 | 105 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2018 | 6773 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2011 | 4554 | 0.040 |
Why?
|
Survival Analysis | 2 | 2016 | 10252 | 0.040 |
Why?
|
Receptor, Melanocortin, Type 4 | 1 | 2019 | 129 | 0.040 |
Why?
|
Curriculum | 1 | 1991 | 3605 | 0.040 |
Why?
|
Ossification, Heterotopic | 1 | 2001 | 239 | 0.040 |
Why?
|
Radioimmunoassay | 1 | 1998 | 919 | 0.040 |
Why?
|
Bicuspid | 1 | 1998 | 74 | 0.040 |
Why?
|
Quality Control | 1 | 2021 | 841 | 0.040 |
Why?
|
Cuspid | 1 | 1998 | 58 | 0.040 |
Why?
|
Health Status | 3 | 2013 | 4034 | 0.040 |
Why?
|
Myocardial Infarction | 3 | 2009 | 11718 | 0.040 |
Why?
|
Models, Statistical | 2 | 2020 | 5101 | 0.040 |
Why?
|
Drug Administration Schedule | 3 | 2014 | 4933 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 1991 | 3841 | 0.040 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 1801 | 0.040 |
Why?
|
Sample Size | 1 | 2021 | 845 | 0.040 |
Why?
|
Troponin T | 1 | 2022 | 754 | 0.040 |
Why?
|
Transforming Growth Factor alpha | 1 | 2017 | 135 | 0.040 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2017 | 24 | 0.040 |
Why?
|
Seasons | 3 | 2010 | 1493 | 0.040 |
Why?
|
Jaw, Edentulous | 1 | 1998 | 93 | 0.040 |
Why?
|
Liver | 4 | 2021 | 7475 | 0.040 |
Why?
|
Molar | 1 | 1998 | 152 | 0.040 |
Why?
|
Dietary Carbohydrates | 1 | 2002 | 905 | 0.040 |
Why?
|
Chi-Square Distribution | 3 | 2000 | 3508 | 0.040 |
Why?
|
Quinacrine | 1 | 1996 | 24 | 0.040 |
Why?
|
Interleukins | 1 | 2021 | 791 | 0.040 |
Why?
|
Supine Position | 1 | 2017 | 205 | 0.040 |
Why?
|
Incisor | 1 | 1998 | 179 | 0.040 |
Why?
|
Physical Education and Training | 1 | 1997 | 106 | 0.040 |
Why?
|
Mutagenesis | 1 | 2021 | 1264 | 0.040 |
Why?
|
Databases, Factual | 3 | 2018 | 7730 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2011 | 4043 | 0.040 |
Why?
|
Bed Rest | 1 | 2016 | 84 | 0.040 |
Why?
|
Stress, Physiological | 1 | 2004 | 1403 | 0.040 |
Why?
|
DNA | 2 | 2000 | 7294 | 0.030 |
Why?
|
Western Australia | 1 | 2015 | 41 | 0.030 |
Why?
|
DNA Primers | 1 | 2000 | 2891 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2019 | 811 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 1997 | 898 | 0.030 |
Why?
|
Disease Progression | 3 | 2018 | 13286 | 0.030 |
Why?
|
Benzamides | 1 | 2001 | 1379 | 0.030 |
Why?
|
RNA-Binding Proteins | 2 | 2019 | 1903 | 0.030 |
Why?
|
Terminology as Topic | 1 | 2022 | 1547 | 0.030 |
Why?
|
Indians, North American | 1 | 2019 | 355 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 711 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2021 | 956 | 0.030 |
Why?
|
HIV Infections | 1 | 2021 | 16715 | 0.030 |
Why?
|
Physical Stimulation | 1 | 2016 | 525 | 0.030 |
Why?
|
Calcium Citrate | 1 | 2014 | 6 | 0.030 |
Why?
|
Pressure | 1 | 2018 | 1203 | 0.030 |
Why?
|
Bone Marrow | 1 | 2005 | 2948 | 0.030 |
Why?
|
Transcription Factors | 2 | 2012 | 12207 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2010 | 21833 | 0.030 |
Why?
|
Stress, Mechanical | 2 | 2011 | 1686 | 0.030 |
Why?
|
Models, Economic | 1 | 2019 | 712 | 0.030 |
Why?
|
Muscular Atrophy | 1 | 2018 | 347 | 0.030 |
Why?
|
Carotid Artery, Common | 1 | 2015 | 183 | 0.030 |
Why?
|
Personnel Selection | 1 | 1996 | 190 | 0.030 |
Why?
|
Tennessee | 1 | 1994 | 117 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1997 | 1681 | 0.030 |
Why?
|
Receptors, Kainic Acid | 1 | 2014 | 88 | 0.030 |
Why?
|
Kentucky | 1 | 1994 | 83 | 0.030 |
Why?
|
Missouri | 1 | 1994 | 117 | 0.030 |
Why?
|
Leadership | 1 | 2024 | 1357 | 0.030 |
Why?
|
Alveolar Bone Loss | 1 | 1998 | 383 | 0.030 |
Why?
|
Hypogonadism | 1 | 2000 | 799 | 0.030 |
Why?
|
Receptors, GABA-B | 1 | 2014 | 68 | 0.030 |
Why?
|
Cadaver | 1 | 2018 | 1337 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2012 | 0.030 |
Why?
|
Potassium Channels, Tandem Pore Domain | 1 | 2014 | 58 | 0.030 |
Why?
|
Sarcoplasmic Reticulum | 1 | 2014 | 158 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2021 | 856 | 0.030 |
Why?
|
Knee | 1 | 2015 | 274 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2013 | 98 | 0.030 |
Why?
|
Adipocytes | 1 | 2021 | 1185 | 0.030 |
Why?
|
Clinical Trials as Topic | 3 | 2021 | 7914 | 0.030 |
Why?
|
Fluoroimmunoassay | 1 | 2013 | 33 | 0.030 |
Why?
|
Receptors, Retinoic Acid | 1 | 2014 | 232 | 0.030 |
Why?
|
Brain Ischemia | 1 | 2008 | 3265 | 0.030 |
Why?
|
Repressor Proteins | 2 | 2017 | 3024 | 0.030 |
Why?
|
Length of Stay | 1 | 2007 | 6311 | 0.030 |
Why?
|
Exons | 1 | 2019 | 2439 | 0.030 |
Why?
|
Dehydroepiandrosterone | 1 | 2014 | 252 | 0.030 |
Why?
|
Androgens | 1 | 2021 | 1281 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 1998 | 768 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2016 | 894 | 0.030 |
Why?
|
Physicians | 1 | 1991 | 4567 | 0.030 |
Why?
|
Preventive Medicine | 1 | 1995 | 264 | 0.030 |
Why?
|
Chickens | 1 | 2015 | 865 | 0.030 |
Why?
|
Myoblasts | 1 | 2014 | 238 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2022 | 2073 | 0.030 |
Why?
|
Models, Biological | 2 | 2001 | 9584 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2019 | 1340 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2017 | 1617 | 0.030 |
Why?
|
Genomic Imprinting | 1 | 2014 | 328 | 0.030 |
Why?
|
Data Collection | 3 | 2006 | 3339 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 3255 | 0.030 |
Why?
|
Metabolomics | 1 | 2021 | 1485 | 0.030 |
Why?
|
Cytokines | 1 | 2007 | 7323 | 0.030 |
Why?
|
Weight Gain | 1 | 2002 | 2293 | 0.030 |
Why?
|
Self-Evaluation Programs | 1 | 1991 | 29 | 0.030 |
Why?
|
Risk Management | 1 | 1995 | 571 | 0.030 |
Why?
|
Qualitative Research | 1 | 2020 | 2682 | 0.030 |
Why?
|
Community Health Services | 1 | 1997 | 650 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1978 | 0.030 |
Why?
|
Spectrin | 1 | 2012 | 177 | 0.030 |
Why?
|
Telomere | 1 | 2018 | 910 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2004 | 3395 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 9274 | 0.030 |
Why?
|
Software | 2 | 2016 | 4441 | 0.030 |
Why?
|
Hemorrhage | 1 | 2023 | 3461 | 0.020 |
Why?
|
Patient Participation | 1 | 2021 | 1457 | 0.020 |
Why?
|
Ribonucleoproteins | 1 | 2014 | 381 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1184 | 0.020 |
Why?
|
DNA Primase | 1 | 2012 | 109 | 0.020 |
Why?
|
Wrist Injuries | 1 | 2014 | 208 | 0.020 |
Why?
|
Muscle Development | 1 | 2013 | 271 | 0.020 |
Why?
|
Gene Expression | 2 | 2017 | 7798 | 0.020 |
Why?
|
Serine Endopeptidases | 1 | 2017 | 1073 | 0.020 |
Why?
|
Chromosomes, Mammalian | 1 | 2012 | 151 | 0.020 |
Why?
|
Internship and Residency | 1 | 1991 | 5791 | 0.020 |
Why?
|
Actin-Related Protein 2-3 Complex | 1 | 2011 | 63 | 0.020 |
Why?
|
Signal Transduction | 1 | 2014 | 23404 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2015 | 4805 | 0.020 |
Why?
|
China | 1 | 2016 | 2245 | 0.020 |
Why?
|
Inositol Phosphates | 1 | 1991 | 180 | 0.020 |
Why?
|
Exodeoxyribonucleases | 1 | 2012 | 180 | 0.020 |
Why?
|
Incidental Findings | 1 | 2015 | 689 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2012 | 426 | 0.020 |
Why?
|
Receptors, Leukotriene B4 | 1 | 1991 | 94 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2012 | 791 | 0.020 |
Why?
|
Cell Aggregation | 1 | 1991 | 244 | 0.020 |
Why?
|
Accidents, Home | 1 | 2010 | 75 | 0.020 |
Why?
|
Sulfotransferases | 1 | 2011 | 151 | 0.020 |
Why?
|
Models, Genetic | 1 | 2000 | 3493 | 0.020 |
Why?
|
Markov Chains | 1 | 2013 | 969 | 0.020 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2014 | 703 | 0.020 |
Why?
|
Cell Count | 1 | 2014 | 1856 | 0.020 |
Why?
|
DNA Repair Enzymes | 1 | 2012 | 349 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2022 | 3390 | 0.020 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 257 | 0.020 |
Why?
|
Body Fat Distribution | 1 | 2011 | 244 | 0.020 |
Why?
|
Ovary | 1 | 2014 | 981 | 0.020 |
Why?
|
Computational Biology | 2 | 2012 | 3519 | 0.020 |
Why?
|
Actins | 1 | 2017 | 2121 | 0.020 |
Why?
|
Physicians, Family | 1 | 1991 | 345 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2010 | 300 | 0.020 |
Why?
|
Endonucleases | 1 | 2012 | 380 | 0.020 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2010 | 374 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2373 | 0.020 |
Why?
|
Carotid Artery Diseases | 1 | 2015 | 879 | 0.020 |
Why?
|
Netherlands | 1 | 2014 | 2170 | 0.020 |
Why?
|
Gene Dosage | 1 | 2013 | 1252 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2014 | 1000 | 0.020 |
Why?
|
Luminescent Measurements | 2 | 2008 | 405 | 0.020 |
Why?
|
Shoes | 1 | 2009 | 97 | 0.020 |
Why?
|
Flatfoot | 1 | 2009 | 55 | 0.020 |
Why?
|
Connective Tissue | 1 | 2011 | 420 | 0.020 |
Why?
|
Biopsy | 2 | 2016 | 6755 | 0.020 |
Why?
|
Cell Death | 1 | 2014 | 1707 | 0.020 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2012 | 486 | 0.020 |
Why?
|
Trauma Severity Indices | 1 | 2010 | 481 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2016 | 1837 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2014 | 1602 | 0.020 |
Why?
|
Mechanotransduction, Cellular | 1 | 2013 | 541 | 0.020 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2011 | 504 | 0.020 |
Why?
|
Family Health | 1 | 2013 | 1281 | 0.020 |
Why?
|
Thyroxine | 1 | 2012 | 667 | 0.020 |
Why?
|
Research | 1 | 1996 | 1999 | 0.020 |
Why?
|
Exercise Test | 1 | 2015 | 2073 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2011 | 391 | 0.020 |
Why?
|
Proteins | 2 | 2014 | 6100 | 0.020 |
Why?
|
Glycosuria | 1 | 1987 | 43 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2012 | 783 | 0.020 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2011 | 469 | 0.020 |
Why?
|
Drug Utilization | 1 | 2014 | 1183 | 0.020 |
Why?
|
Pyuria | 1 | 1987 | 30 | 0.020 |
Why?
|
Psychological Tests | 1 | 2010 | 651 | 0.020 |
Why?
|
Stem Cells | 1 | 2021 | 3567 | 0.020 |
Why?
|
Blood Pressure | 1 | 2023 | 8551 | 0.020 |
Why?
|
Sexual Maturation | 1 | 2009 | 265 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2009 | 460 | 0.020 |
Why?
|
Physicians' Offices | 1 | 1987 | 58 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4162 | 0.020 |
Why?
|
Intelligence Tests | 1 | 2008 | 505 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2008 | 964 | 0.020 |
Why?
|
Nitrites | 1 | 1987 | 160 | 0.020 |
Why?
|
Computer Simulation | 1 | 2000 | 6194 | 0.020 |
Why?
|
Dexamethasone | 1 | 2014 | 1951 | 0.020 |
Why?
|
Pulmonary Alveoli | 2 | 1987 | 675 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2887 | 0.020 |
Why?
|
Bacteriuria | 1 | 1987 | 102 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2009 | 15297 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2012 | 1152 | 0.020 |
Why?
|
Eicosapentaenoic Acid | 1 | 2011 | 582 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2016 | 1708 | 0.020 |
Why?
|
Receptors, Complement | 1 | 1987 | 264 | 0.020 |
Why?
|
Health Services Research | 1 | 1994 | 1836 | 0.020 |
Why?
|
Immunoassay | 1 | 2010 | 752 | 0.020 |
Why?
|
Inpatients | 1 | 2018 | 2518 | 0.020 |
Why?
|
Osteosclerosis | 1 | 2006 | 39 | 0.020 |
Why?
|
Health Promotion | 2 | 1997 | 2205 | 0.020 |
Why?
|
DNA Helicases | 1 | 2012 | 861 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2012 | 970 | 0.020 |
Why?
|
Neutrophils | 2 | 1991 | 3721 | 0.020 |
Why?
|
Reagent Kits, Diagnostic | 1 | 1987 | 224 | 0.020 |
Why?
|
Urination Disorders | 1 | 1987 | 241 | 0.020 |
Why?
|
gamma-Globulins | 1 | 1985 | 124 | 0.020 |
Why?
|
Hematuria | 1 | 1987 | 235 | 0.020 |
Why?
|
Physical Fitness | 2 | 2002 | 732 | 0.020 |
Why?
|
Gene Deletion | 1 | 2013 | 2751 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 2016 | 2148 | 0.020 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2007 | 297 | 0.020 |
Why?
|
Drug Combinations | 1 | 2011 | 1958 | 0.020 |
Why?
|
Homozygote | 1 | 2010 | 1787 | 0.020 |
Why?
|
Cephalosporins | 1 | 1986 | 204 | 0.020 |
Why?
|
Adiponectin | 1 | 2011 | 1101 | 0.020 |
Why?
|
Decision Making | 1 | 2019 | 3888 | 0.020 |
Why?
|
Health Behavior | 1 | 1997 | 2635 | 0.020 |
Why?
|
Syphilis | 1 | 1987 | 227 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4185 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4042 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3505 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1862 | 0.020 |
Why?
|
Cell Line | 2 | 2014 | 16000 | 0.020 |
Why?
|
Canada | 1 | 2010 | 2065 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3707 | 0.020 |
Why?
|
Blepharoptosis | 1 | 1986 | 143 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2007 | 906 | 0.020 |
Why?
|
Social Support | 1 | 1994 | 2118 | 0.020 |
Why?
|
Sunlight | 1 | 2006 | 325 | 0.020 |
Why?
|
Smoking Cessation | 1 | 2016 | 2071 | 0.020 |
Why?
|
Docosahexaenoic Acids | 1 | 2011 | 875 | 0.020 |
Why?
|
Proteinuria | 1 | 1987 | 658 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2018 | 3864 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2011 | 2715 | 0.010 |
Why?
|
Plaque, Atherosclerotic | 1 | 2015 | 1519 | 0.010 |
Why?
|
Glycoproteins | 1 | 2012 | 2266 | 0.010 |
Why?
|
Macrophages | 3 | 1987 | 5660 | 0.010 |
Why?
|
Streptococcus agalactiae | 1 | 1985 | 375 | 0.010 |
Why?
|
Telemedicine | 1 | 2021 | 2872 | 0.010 |
Why?
|
International Cooperation | 1 | 2010 | 1420 | 0.010 |
Why?
|
Receptors, Fc | 1 | 1987 | 541 | 0.010 |
Why?
|
Phagocytosis | 2 | 1987 | 1539 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2007 | 1263 | 0.010 |
Why?
|
Blood Glucose | 2 | 2012 | 6254 | 0.010 |
Why?
|
Down-Regulation | 1 | 1991 | 3001 | 0.010 |
Why?
|
Patient Discharge | 1 | 2016 | 3318 | 0.010 |
Why?
|
Hippocampus | 1 | 2015 | 3675 | 0.010 |
Why?
|
Cataract | 1 | 1989 | 834 | 0.010 |
Why?
|
Disease Models, Animal | 4 | 2015 | 18034 | 0.010 |
Why?
|
Neoplasms | 1 | 2012 | 21696 | 0.010 |
Why?
|
Absorption | 1 | 2002 | 248 | 0.010 |
Why?
|
Parkinson Disease | 1 | 1996 | 2775 | 0.010 |
Why?
|
Fibronectins | 1 | 1985 | 726 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1997 | 4034 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 1987 | 2242 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 3677 | 0.010 |
Why?
|
Primary Health Care | 2 | 2003 | 4557 | 0.010 |
Why?
|
Biological Availability | 1 | 2002 | 397 | 0.010 |
Why?
|
Binding Sites | 1 | 2010 | 6111 | 0.010 |
Why?
|
Radioligand Assay | 1 | 2001 | 374 | 0.010 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2001 | 129 | 0.010 |
Why?
|
Digestive System | 1 | 2002 | 253 | 0.010 |
Why?
|
Insulin | 2 | 2012 | 6582 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2011 | 2916 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2917 | 0.010 |
Why?
|
Time | 1 | 2002 | 542 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8385 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2007 | 1837 | 0.010 |
Why?
|
Structure-Activity Relationship | 2 | 2001 | 3130 | 0.010 |
Why?
|
Family Practice | 1 | 2003 | 516 | 0.010 |
Why?
|
New England | 1 | 2003 | 1022 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3873 | 0.010 |
Why?
|
Contraceptives, Oral | 1 | 2002 | 564 | 0.010 |
Why?
|
Therapeutic Equivalency | 1 | 2000 | 141 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2001 | 667 | 0.010 |
Why?
|
Societies, Medical | 1 | 2012 | 3743 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2002 | 11126 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2013 | 7785 | 0.010 |
Why?
|
Glucagon | 1 | 2001 | 533 | 0.010 |
Why?
|
Sporothrix | 1 | 1978 | 2 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2018 | 25628 | 0.010 |
Why?
|
Mitosporic Fungi | 1 | 1978 | 20 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8319 | 0.010 |
Why?
|
Nasal Cavity | 1 | 2000 | 313 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2014 | 20824 | 0.010 |
Why?
|
Luteinizing Hormone | 1 | 2000 | 869 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2007 | 2355 | 0.010 |
Why?
|
Ascomycota | 1 | 1978 | 82 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2001 | 1892 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2001 | 1472 | 0.010 |
Why?
|
Coronary Angiography | 1 | 1989 | 4576 | 0.010 |
Why?
|
Cross Reactions | 1 | 1978 | 841 | 0.010 |
Why?
|
Lipids | 1 | 2007 | 3307 | 0.010 |
Why?
|
Monocytes | 1 | 1985 | 2596 | 0.010 |
Why?
|
Clinical Competence | 1 | 1991 | 4687 | 0.010 |
Why?
|
Infant | 1 | 2018 | 35134 | 0.010 |
Why?
|
Fees and Charges | 1 | 1996 | 195 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2007 | 6994 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 1993 | 7658 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2000 | 1530 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 1987 | 2988 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2005 | 35425 | 0.010 |
Why?
|
Pain | 1 | 2008 | 4988 | 0.010 |
Why?
|
Epithelium | 1 | 1997 | 1679 | 0.010 |
Why?
|
Dogs | 2 | 1987 | 3912 | 0.010 |
Why?
|
Lymph Nodes | 2 | 1997 | 3476 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 2000 | 1170 | 0.010 |
Why?
|
Mutation | 1 | 2015 | 29786 | 0.010 |
Why?
|
Mice, Nude | 1 | 1997 | 3689 | 0.010 |
Why?
|
Reaction Time | 1 | 1997 | 2098 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2001 | 8300 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2003 | 3531 | 0.010 |
Why?
|
Cell Division | 1 | 1997 | 4569 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2001 | 8642 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 1997 | 6386 | 0.000 |
Why?
|
Health Education | 1 | 1995 | 1056 | 0.000 |
Why?
|
Staphylococcus aureus | 2 | 1986 | 1453 | 0.000 |
Why?
|
Peritoneal Cavity | 1 | 1987 | 148 | 0.000 |
Why?
|
Haemophilus influenzae | 1 | 1986 | 172 | 0.000 |
Why?
|
Hospitals, Teaching | 1 | 1990 | 1180 | 0.000 |
Why?
|
Rats | 1 | 2001 | 24252 | 0.000 |
Why?
|
Macrophage Activation | 1 | 1987 | 560 | 0.000 |
Why?
|
Endotoxins | 1 | 1986 | 527 | 0.000 |
Why?
|
Cricetinae | 1 | 1987 | 2475 | 0.000 |
Why?
|
Leukocyte Count | 1 | 1987 | 1588 | 0.000 |
Why?
|
Hydrogen Peroxide | 1 | 1986 | 730 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1985 | 2646 | 0.000 |
Why?
|
Biological Transport | 1 | 1986 | 2120 | 0.000 |
Why?
|
Microbial Sensitivity Tests | 1 | 1986 | 1877 | 0.000 |
Why?
|
Cell Adhesion | 1 | 1987 | 3144 | 0.000 |
Why?
|
Shock, Septic | 1 | 1986 | 775 | 0.000 |
Why?
|
Fetal Blood | 1 | 1985 | 1318 | 0.000 |
Why?
|
Rhamnose | 1 | 1978 | 18 | 0.000 |
Why?
|
Immunodiffusion | 1 | 1978 | 163 | 0.000 |
Why?
|
Kinetics | 1 | 1986 | 6476 | 0.000 |
Why?
|
Mannose | 1 | 1978 | 124 | 0.000 |
Why?
|
Precipitin Tests | 1 | 1978 | 829 | 0.000 |
Why?
|
Cell Survival | 1 | 1986 | 5882 | 0.000 |
Why?
|
Escherichia coli | 1 | 1986 | 4217 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1997 | 13104 | 0.000 |
Why?
|
Rabbits | 1 | 1978 | 4894 | 0.000 |
Why?
|
Pregnancy | 1 | 1985 | 29144 | 0.000 |
Why?
|